✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Recursion Pharmaceuticals Inc

Common Name
Recursion Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
600
Ticker
RXRX
Exchange
NASDAQ/NGS
Description
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on decoding biology to industrialize drug discovery. It integrates technological innovations across biology, chemistry...

Recursion Pharmaceuticals's Energy Data Preview

In 2024, Recursion Pharmaceuticals disclosed key data related to its energy management practices, providing transparency into its operational energy use in line with recognized sustainability reporting frameworks.

Metric (GJ)2024202320222021-2019
Total Energy Consumption
32,585a
25,036a
8,980a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Recursion Pharmaceuticals’s Energy Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Recursion Pharmaceuticals's ESG Report 2024
Want Full Access to Recursion Pharmaceuticals's Energy Dataset?
Start 30-Day Free Trial